Objective: The aim of this study was to determine the clinical role of the systemic immune-
inflammation index in patients with resectable adenocarcinoma of the gastroesophageal …

Background The systemic immune-inflammation index based on peripheral neutrophil,
lymphocyte, and platelet counts has shown a prognostic impact in several malignancies …

Background Esophageal adenocarcinoma (EAC) has a poor prognosis; predictive markers
of prognosis would facilitate advances in personalized therapy. C-reactive protein (CRP) …

In recent years, some studies suggested that the pretreatment C‐reactive protein to albumin
ratio (CAR) may be predictive for prognosis of esophageal cancer (EC), but their results …

Plenty of studies have confirmed the prognostic values of inflammation-based prognostic
scores in many malignant tumors. In present study, we aim to explore whether these indexes …

Background: Numerous studies have reported that systemic immune-inflammation index
(SII) and C-reactive protein-to-albumin ratio (CAR) correlate with tumor progression and …

Increasing evidences support that systemic inflammation-based prognostic scores, modified
Glasgow Prognostic Score (mGPS), C-reactive Protein/Albumin (CRP/ALB) …

Abstract The modified Glasgow Prognostic Score (mGPS) combines the indicators of
decreased plasma albumin and elevated CRP. In a number of malignancies, elevated …

Background/Aim: Several immunoinflammatory and nutritional measures have been
reported to be good prognostic indicators for esophageal cancer (EC). However, the …

Background Although radical esophagectomy with multifield lymph node dissection is a
promising treatment to achieve long-term survival for resectable esophageal cancer, survival …